MISSO, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 1.925
EU - Europa 1.676
AS - Asia 453
SA - Sud America 5
AF - Africa 4
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.068
Nazione #
US - Stati Uniti d'America 1.921
IE - Irlanda 554
IT - Italia 361
GB - Regno Unito 186
UA - Ucraina 182
DE - Germania 164
SG - Singapore 138
CN - Cina 123
VN - Vietnam 72
FI - Finlandia 66
GR - Grecia 55
TR - Turchia 45
FR - Francia 36
SE - Svezia 29
PK - Pakistan 19
KR - Corea 18
BE - Belgio 15
CZ - Repubblica Ceca 11
IR - Iran 10
IN - India 8
JP - Giappone 5
AT - Austria 4
AU - Australia 4
BR - Brasile 4
CA - Canada 4
NL - Olanda 4
TW - Taiwan 4
ES - Italia 3
HK - Hong Kong 3
IL - Israele 3
SC - Seychelles 3
RU - Federazione Russa 2
AM - Armenia 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
ID - Indonesia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
PE - Perù 1
QA - Qatar 1
SI - Slovenia 1
Totale 4.068
Città #
Dublin 554
Santa Clara 315
Chandler 308
Jacksonville 300
Singapore 87
Ann Arbor 81
New York 73
Dong Ket 72
Ashburn 69
Princeton 69
Medford 61
Bremen 60
Beijing 53
Roxbury 53
Boardman 51
Caserta 42
Naples 38
Woodbridge 36
Aversa 32
Wilmington 29
Des Moines 24
San Mateo 20
Munich 19
Napoli 19
Brussels 15
Mountain View 15
Seoul 15
Helsinki 14
Brno 11
Cambridge 11
Milan 10
San Nicola la Strada 10
Rome 9
Falls Church 8
Bahawalpur 7
Cava Dei Tirreni 7
Zhengzhou 7
Düsseldorf 6
Los Angeles 6
Piscataway 6
Auburn Hills 5
Avellino 5
Houston 5
Nanjing 5
Tianjin 5
Ercolano 4
Gunzenhausen 4
Istanbul 4
Lappeenranta 4
London 4
Taipei 4
Vienna 4
Bascape 3
Castellammare Di Stabia 3
Clifton 3
Guangzhou 3
Jerusalem 3
Jinan 3
Madrid 3
Norwalk 3
Nottingham 3
Novara 3
San Giorgio a Cremano 3
Saviano 3
Washington 3
Capri 2
Castel Volturno 2
Colleferro 2
Forino 2
Frankfurt am Main 2
Groningen 2
Haikou 2
Hangzhou 2
Hebei 2
Hefei 2
Hong Kong 2
Latina 2
Melbourne 2
Miami 2
Newark 2
North Bergen 2
Prata 2
Pune 2
Redwood City 2
San Felice A Cancello 2
Seattle 2
Shanghai 2
Shenyang 2
São Paulo 2
Tricase 2
Vellore 2
Aigaleo 1
Amsterdam 1
Athens 1
Bishkek 1
Bolzano 1
Caiazzo 1
Campania 1
Campobasso 1
Campodarsego 1
Totale 2.775
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 102
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 87
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 86
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 84
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 80
Mitochondria as playmakers of apoptosis, autophagy and senescence 78
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 77
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 76
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 70
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 69
Gene interference strategies as a new tool for the treatment of prostate cancer 68
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 67
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 66
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 65
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 65
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 64
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 63
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 63
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 63
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 62
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 62
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 61
Emerging pathways as individualized therapeutic target of multiple myeloma. 61
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 61
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 59
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 59
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 59
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 58
Bisphosphonates and cancer: what opportunities from nanotechnology? 58
Optimal Management of Prostate Cancer Based on its Natural Clinical History 58
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 58
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 56
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 56
Measurement of autophagy by flow cytometry 56
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 56
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 54
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 54
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 54
Tumour-specific uptake of anti-cancer drugs: the future is here. 53
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 52
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 52
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 52
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 52
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 51
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 50
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 49
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 49
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 49
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 47
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 47
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 47
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 47
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 47
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 46
Mir-34: a new weapon against cancer? 46
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 44
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 43
Role of perineural invasion as a prognostic factor in laryngeal cancer 43
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 43
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 42
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 41
Lipid Nanoparticles to Deliver miRNA in Cancer 40
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 39
Hepatocarcinoma: genetic and epigenetic features 38
Non-coding RNAs as a new dawn in tumor diagnosis 38
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 35
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 34
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 34
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 34
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 34
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 34
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 30
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 30
Immune cell infiltration and inflammatory landscape in primary brain tumours 29
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 25
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 24
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 22
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 21
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 21
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 19
Nanoparticelle e loro usi 19
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 18
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 18
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 18
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 16
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 16
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 16
Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study 11
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 9
Flexible 3D nanofiber-based SERS biosensor for detection of miRNA-223-3p in early Laryngeal Cancer diagnosis 2
Totale 4.311
Categoria #
all - tutte 19.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020199 0 0 0 0 0 11 77 22 26 21 29 13
2020/2021525 39 6 57 27 60 13 64 47 29 42 61 80
2021/2022444 23 12 1 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/2025572 27 31 6 85 232 191 0 0 0 0 0 0
Totale 4.311